A detailed history of Guggenheim Capital LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 358,486 shares of MRK stock, worth $35.7 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
358,486
Previous 394,358 9.1%
Holding current value
$35.7 Million
Previous $48.8 Million 16.62%
% of portfolio
0.29%
Previous 0.35%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $3.99 Million - $4.63 Million
-35,872 Reduced 9.1%
358,486 $40.7 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $6.92 Million - $7.43 Million
-55,875 Reduced 12.41%
394,358 $48.8 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $12.8 Million - $14.9 Million
-112,727 Reduced 20.02%
450,233 $59.4 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $3.98 Million - $4.33 Million
-39,715 Reduced 6.59%
562,960 $61.4 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $14 Million - $15.6 Million
-136,123 Reduced 18.42%
602,675 $62 Million
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $11.3 Million - $12.3 Million
-103,694 Reduced 12.31%
738,798 $85.2 Million
Q1 2023

May 10, 2023

SELL
$102.94 - $114.86 $9.12 Million - $10.2 Million
-88,587 Reduced 9.51%
842,492 $89.6 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $6.08 Million - $7.8 Million
-69,545 Reduced 6.95%
931,079 $103 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $20,625 - $23,170
-244 Reduced 0.02%
1,000,624 $86.2 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $496,682 - $563,013
5,949 Added 0.6%
1,000,868 $91.2 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $5.77 Million - $6.47 Million
78,527 Added 8.57%
994,919 $81.6 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $2.89 Million - $3.62 Million
39,983 Added 4.56%
916,392 $70.2 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $7.94 Million - $8.74 Million
110,834 Added 14.48%
876,409 $65.8 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $5.92 Million - $6.54 Million
84,133 Added 12.35%
765,575 $59.5 Million
Q1 2021

May 13, 2021

BUY
$68.86 - $81.11 $5.29 Million - $6.23 Million
76,822 Added 12.71%
681,442 $52.5 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $5.46 Million - $6.06 Million
76,114 Added 14.4%
604,620 $49.5 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $5.49 Million - $6.23 Million
75,059 Added 16.55%
528,506 $43.8 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $911,023 - $1.04 Million
12,937 Added 2.94%
453,447 $35.1 Million
Q1 2020

Jun 02, 2020

SELL
$63.36 - $87.82 $5.1 Million - $7.07 Million
-80,522 Reduced 15.45%
440,510 $33.9 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $705,745 - $796,351
9,097 Added 1.78%
521,032 $47.4 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $3.28 Million - $3.57 Million
-43,049 Reduced 7.76%
511,935 $43.1 Million
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $404,443 - $472,487
-5,791 Reduced 1.03%
554,984 $46.5 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $8.64 Million - $9.85 Million
-124,161 Reduced 18.13%
560,775 $46.6 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $2.53 Million - $2.94 Million
38,854 Added 6.01%
684,936 $52.3 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $5.6 Million - $6.58 Million
97,030 Added 17.67%
646,082 $45.8 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $53.8 Million - $63.2 Million
-1,058,945 Reduced 65.85%
549,052 $33.3 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $3.43 Million - $3.99 Million
67,331 Added 4.37%
1,607,997 $87.6 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $7.17 Million - $8.56 Million
138,831 Added 9.9%
1,540,666 $86.7 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $82.2 Million - $88.5 Million
1,401,835
1,401,835 $89.8 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.